Literature DB >> 15138458

Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus.

Marta Barreto1, Eugénia Santos, Ricardo Ferreira, Constantin Fesel, Maria Francisca Fontes, Clara Pereira, Berta Martins, Rita Andreia, João Faro Viana, Francisco Crespo, Carlos Vasconcelos, Carlos Ferreira, Astrid Moura Vicente.   

Abstract

Several lines of evidence implicate the Cytotoxic T Lymphocyte Antigen 4 (CTLA4) gene in susceptibility to autoimmune disease. We have examined the association of systemic lupus erythematosus (SLE) with polymorhisms within the CTLA4 gene that were previously proposed to regulate CTLA-4 function: a single nucleotide polymorphism (SNP) in position +49 of exon 1 and a dinucleotide repeat in the 3' untranslated region (3'UTR). The 3'UTR repeat showed a significant association with SLE, with one allele conferring susceptibility and another conferring protection to the disease. The associated alleles do not support previous suggestions of an allele size-dependent effect of the 3' UTR polymorphism in autoimmunity development and instead suggest that it is in linkage disequilibrium with a true causative locus. No association of the exon 1 SNP with SLE was found in our population. Given the conflicting results obtained in different studies on the association of SLE with this polymorphism, we performed a meta-analysis including seven previously published studies and the present one. Significantly increased and decreased risks for SLE were found for carriers of the G allele and the A allele, respectively. The functional characterization of disease-associated CTLA4 gene variants is now required to elucidate their role in the pathogenesis of SLE and other autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138458     DOI: 10.1038/sj.ejhg.5201214

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  28 in total

1.  Interaction between CTLA4 gene and IBD5 locus in Hungarian Crohn's disease patients.

Authors:  Veronika Csöngei; Luca Járomi; Eniko Sáfrány; Csilla Sipeky; Lili Magyari; Noémi Polgár; Judit Bene; Patrícia Sarlós; Lilla Lakner; Eszter Baricza; Melinda Szabó; Gábor Rappai; Béla Melegh
Journal:  Int J Colorectal Dis       Date:  2011-04-26       Impact factor: 2.571

2.  Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus.

Authors:  Travis Hughes; Adam Adler; Jennifer A Kelly; Kenneth M Kaufman; Adrienne H Williams; Carl D Langefeld; Elizabeth E Brown; Graciela S Alarcón; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle Petri; Susan A Boackle; Anne M Stevens; John D Reveille; Elena Sanchez; Javier Martín; Timothy B Niewold; Luis M Vilá; R Hal Scofield; Gary S Gilkeson; Patrick M Gaffney; Lindsey A Criswell; Kathy L Moser; Joan T Merrill; Chaim O Jacob; Betty P Tsao; Judith A James; Timothy J Vyse; Marta E Alarcón-Riquelme; John B Harley; Bruce C Richardson; Amr H Sawalha
Journal:  Arthritis Rheum       Date:  2012-02

3.  Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy.

Authors:  Volker Ruppert; Thomas Meyer; Clarissa Struwe; Jana Petersen; Andreas Perrot; Maximilian G Posch; Cemil Ozcelik; Anette Richter; Bernhard Maisch; Sabine Pankuweit
Journal:  Eur J Hum Genet       Date:  2010-02-10       Impact factor: 4.246

4.  Remapping the type I diabetes association of the CTLA4 locus.

Authors:  H-Q Qu; J P Bradfield; S F A Grant; H Hakonarson; C Polychronakos
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

Review 5.  Genes and Sjögren's syndrome.

Authors:  Beth L Cobb; Christopher J Lessard; John B Harley; Kathy L Moser
Journal:  Rheum Dis Clin North Am       Date:  2008-11       Impact factor: 2.670

6.  Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity.

Authors:  Suad AlFadhli
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-28

7.  B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ.

Authors:  Elisabeth Salzer; Elisangela Santos-Valente; Stefanie Klaver; Sol A Ban; Wolfgang Emminger; Nina Kathrin Prengemann; Wojciech Garncarz; Leonhard Müllauer; Renate Kain; Heidrun Boztug; Andreas Heitger; Klaus Arbeiter; Franz Eitelberger; Markus G Seidel; Wolfgang Holter; Arnold Pollak; Winfried F Pickl; Elisabeth Förster-Waldl; Kaan Boztug
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

8.  CTLA-4 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis.

Authors:  Jie Liu; Hong-Xin Zhang
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-05

9.  Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus.

Authors:  Javier Martin; Marta E Alarcón-Riquelme; Angélica M Delgado-Vega; Anna-Karin Abelson; Elena Sánchez; Torsten Witte; Sandra D'Alfonso; Mauro Galeazzi; Juan Jiménez-Alonso; Bernardo A Pons-Estel
Journal:  Genes Immun       Date:  2008-12-18       Impact factor: 2.676

10.  CTLA-4 +49 A/G genotype and HLA-DRB1 polymorphisms in Turkish patients with Henoch-Schönlein purpura.

Authors:  Oguz Soylemezoglu; Harun Peru; Sevim Gonen; Aysun Cetinyurek; Ozan Ozkaya; Sevcan Bakkaloğlu; Necla Buyan; Enver Hasanoglu
Journal:  Pediatr Nephrol       Date:  2008-05-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.